pneumonia: a study of 6 patients with progressive disease.
Candidate biomarkers for idiopathic pulmonary fibrosis (IPF) KL-6: Krebs von den Lungen-6; SP: surfactant protein; MMP: matrix metalloproteinase; ILD: interstitial
lung disease; IIP: idiopathic interstitial
pneumonia; VEGF: vascular endothelial growth factor; IL: interleukin.
The thoracic CT revealed the same mass and furthermore, verities compatible with interstitial
lung disease (Figure 1).
In this study, researchers characterized the presence of interstitial
lung abnormalities in 2416 participants from the COPDGene study.
There is little in the literature regarding the optimal approach to and repair of interstitial
decompression of interstitial
blebs resulting in pneumomediastinum, pneumothorax, pneumopericardium, pneumoperitoneum and or surgical emphysema.
It is from these basic anatomic concepts of the lung interstitium that the patterns of interstitial
lung disease emerge.
KL-6 is a serum marker highly specific for interstitial
A number of conditions make up the disorders called interstitial
lung disease, with most causing scarring of lung tissue, eventually affecting your ability to breathe and get enough oxygen into your bloodstream.
Conditions which are associated with interstitial
fibrosis at the lung bases, such as asbestosis, usual interstitial
pneumonia, scleroderma and rheumatoid lung, are commonly associated with a decrease in lung volume on the chest radiograph over time.
lung diseases (ILDs) are a very heterogeneous group of disorders with distinct clinical courses, radiographic patterns and histology.
today announced their conclusion of a joint research agreement for development of a new KL-6 test kit consisting of an in-vitro, supplementary diagnostic marker for interstitial
pneumonia compatible with LUMIPULSE (automatic chemiluminescent enzyme immunoassay) systems.